HealthInvest Partners AB Cuts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

HealthInvest Partners AB lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 35,202 shares of the healthcare conglomerate’s stock after selling 288 shares during the period. UnitedHealth Group makes up about 8.3% of HealthInvest Partners AB’s holdings, making the stock its 2nd biggest position. HealthInvest Partners AB’s holdings in UnitedHealth Group were worth $17,876,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Conscious Wealth Investments LLC raised its stake in UnitedHealth Group by 4.4% during the 4th quarter. Conscious Wealth Investments LLC now owns 5,507 shares of the healthcare conglomerate’s stock worth $2,807,000 after buying an additional 232 shares during the period. Cherry Tree Wealth Management LLC raised its position in shares of UnitedHealth Group by 6.9% during the fourth quarter. Cherry Tree Wealth Management LLC now owns 871 shares of the healthcare conglomerate’s stock worth $440,000 after purchasing an additional 56 shares during the period. Colonial River Investments LLC grew its position in UnitedHealth Group by 3.0% in the 4th quarter. Colonial River Investments LLC now owns 2,758 shares of the healthcare conglomerate’s stock valued at $1,395,000 after purchasing an additional 81 shares during the period. Y Intercept Hong Kong Ltd raised its holdings in UnitedHealth Group by 41.6% during the fourth quarter. Y Intercept Hong Kong Ltd now owns 8,452 shares of the healthcare conglomerate’s stock worth $4,276,000 after buying an additional 2,483 shares during the last quarter. Finally, Black Diamond Financial LLC grew its holdings in shares of UnitedHealth Group by 4.2% during the fourth quarter. Black Diamond Financial LLC now owns 1,272 shares of the healthcare conglomerate’s stock valued at $643,000 after buying an additional 51 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. KeyCorp reiterated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Piper Sandler cut their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Finally, HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $465.58 on Monday. The firm’s 50 day moving average is $519.27 and its 200 day moving average is $560.44. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market capitalization of $428.46 billion, a P/E ratio of 30.04, a PEG ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the company posted $5.83 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.33% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.